Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Omeros Corp (OMER)

Omeros Corp (OMER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 229,457
  • Shares Outstanding, K 62,865
  • Annual Sales, $ 0 K
  • Annual Income, $ 47,420 K
  • 60-Month Beta 1.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OMER with:

Options Overview Details

View History
  • Implied Volatility 106.65% ( -109.06%)
  • Historical Volatility 107.77%
  • IV Percentile 50%
  • IV Rank 14.13%
  • IV High 425.44% on 11/01/23
  • IV Low 54.18% on 10/26/23
  • Put/Call Vol Ratio 0.07
  • Today's Volume 523
  • Volume Avg (30-Day) 713
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 18,665
  • Open Int (30-Day) 19,584

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +136,949.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.36 +4.92%
on 03/18/24
4.91 -28.31%
on 02/20/24
-1.37 (-28.02%)
since 02/16/24
3-Month
2.76 +27.54%
on 01/04/24
5.14 -31.45%
on 02/16/24
+0.64 (+22.22%)
since 12/18/23
52-Week
0.92 +282.61%
on 10/16/23
7.80 -54.86%
on 06/05/23
-0.02 (-0.56%)
since 03/17/23

Most Recent Stories

More News
Omeros: Q3 Earnings Snapshot

Omeros: Q3 Earnings Snapshot

OMER : 3.52 (-3.56%)
Omeros: Q2 Earnings Snapshot

Omeros: Q2 Earnings Snapshot

OMER : 3.52 (-3.56%)
Why Shares of Omeros Dropped on Monday

The clinical-stage biopharmaceutical released trials data through a presentation.

OMER : 3.52 (-3.56%)
Omeros: Q1 Earnings Snapshot

Omeros: Q1 Earnings Snapshot

OMER : 3.52 (-3.56%)
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2023, on Tuesday, May 9, 2023, after the market closes....

OMER : 3.52 (-3.56%)
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria

Omeros Corporation (Nasdaq: OMER) today announced positive results from a pre-specified interim analysis of its ongoing Phase 1b clinical trial of OMS906, the company’s lead MASP-3 inhibitor, in complement-inhibitor-naïve...

OMER : 3.52 (-3.56%)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END

CELH : 89.54 (-3.62%)
RXDX : 199.92 (+0.09%)
HUGE : 0.7350 (+2.81%)
OMER : 3.52 (-3.56%)
MRK : 121.44 (-0.07%)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

/PRNewswire/ -- Alcohol consumption and drug abuse have become public health concerns worldwide. Governments are working on ways to detect any symptoms of...

CELH : 89.54 (-3.62%)
HUGE : 0.7350 (+2.81%)
OMER : 3.52 (-3.56%)
MRK : 121.44 (-0.07%)
RXDX : 199.92 (+0.09%)
Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program

Omeros Corporation (Nasdaq: OMER) today announced that it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to develop Omeros’ lead...

OMER : 3.52 (-3.56%)
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day

Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day.

CAR : 108.12 (+0.39%)
VMC : 269.42 (+0.96%)
OMER : 3.52 (-3.56%)
LNTH : 56.52 (-2.84%)
HYPR : 1.1900 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 3.99
2nd Resistance Point 3.83
1st Resistance Point 3.67
Last Price 3.52
1st Support Level 3.36
2nd Support Level 3.20
3rd Support Level 3.04

See More

52-Week High 7.80
Fibonacci 61.8% 5.17
Fibonacci 50% 4.36
Fibonacci 38.2% 3.55
Last Price 3.52
52-Week Low 0.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar